Marotta Asset Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-639
Closed -$249K 110
2025
Q2
$249K Sell
639
-1
-0.2% -$402 0.05% 88
2025
Q1
$333K Buy
640
+1
+0.2% +$401 0.07% 94
2024
Q4
$234K Sell
639
-1
-0.2% -$418 0.05% 101
2024
Q3
$333K Hold
640
0.07% 94
2024
Q2
$342K Sell
640
-10
-2% -$5.29K 0.07% 88
2024
Q1
$337K Sell
650
-6
-0.9% -$2.98K 0.07% 85
2023
Q4
$309K Sell
656
-51
-7% -$23.6K 0.07% 88
2023
Q3
$308K Hold
707
0.07% 91
2023
Q2
$314K Buy
+707
New +$326K 0.07% 86
2022
Q4
$406K Buy
791
+54
+7% +$27.4K 0.1% 73
2022
Q3
$335K Hold
737
0.09% 76
2022
Q2
$358K Buy
737
+76
+11% +$37.6K 0.09% 80
2022
Q1
$325K Buy
661
+138
+26% +$63.1K 0.08% 86
2021
Q4
$242K Buy
+523
New +$220K 0.05% 96
2021
Q3
Sell
-523
Closed -$201K 103
2021
Q2
$201K Buy
+523
New +$200K 0.05% 97

Other funds holding ELV

Marotta Asset Management's ELV Position: Q3 2025 in Review

Marotta Asset Management sold out of Elevance Health (ELV) in Q3 2025, closing a stake of 639 shares — an estimated $249K sold.

Marotta Asset Management first reported a position in ELV in Q2 2021 and held it in 15 quarters. The position peaked at $406K in Q4 2022. 1,510 funds tracked by Wall St. Rank hold ELV as of Q3 2025.

  • Marotta Asset Management reported no remaining Elevance Health position as of Q3 2025 after selling out during the quarter.
  • Marotta Asset Management sold 639 Elevance Health shares in Q3 2025, an estimated $249K.
  • Marotta Asset Management first reported a position in Elevance Health in Q2 2021 and held it in 15 quarters.
  • Marotta Asset Management's Elevance Health position peaked at $406K in Q4 2022.
  • 1,510 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.

Based on Marotta Asset Management's 13F filing for Q3 2025, filed 16 Oct 2025.